Hope on the Horizon: Recent Research Breakthroughs

The information below was initiallly shared on November 11, 2025.

Long COVID: Scientists have identified the first potential biomarker for Long COVID by detecting SARS-CoV-2 protein fragments in tiny cellular packages in the blood of affected patients TheanalyticalscientistScienceDaily. Researchers in Japan have also discovered that Long COVID brain fog is connected to measurable changes in AMPA receptors in the brain, and their imaging technique can distinguish Long COVID patients from healthy individuals with 100% sensitivity and 91% specificity ScienceDailySciTechDaily. These discoveries could finally enable objective diagnosis and targeted treatments.

Fibromyalgia: Researchers at the University of Aberdeen and Academia Sinica have

identified a distinct physiological pathway specific to chronic pain that is different from acute pain University of Aberdeen. This groundbreaking discovery means scientists can now develop new treatments specifically targeting this pathway, offering hope for conditions like fibromyalgia that don't respond well to standard painkillers University of Aberdeen.

ME/CFS: A major study analyzing patient-reported outcomes from over 3,900 individuals with ME/CFS and Long COVID has identified treatments perceived as beneficial and revealed significant overlap in symptom profiles between the two conditions, suggesting they may share underlying mechanisms PNAS. Additionally, a new UK-funded PhD project is using advanced technologies to identify biomarkers and infection markers in ME/CFS, which could pave the way for future diagnostics and targeted treatments The ME Association.